TrialBMC cancer2017

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.

Aleksandar Sekulic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.